Viewing Study NCT02167360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-03-06 @ 5:48 PM
Study NCT ID: NCT02167360
Status: WITHDRAWN
Last Update Posted: 2017-02-14
First Post: 2014-06-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Efficacy and Safety of CTL019 in Adult ALL Patients
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Acute Lymphoblastic Leukemia View
None Relapsed B-cell Acute Lymphoblastic Leukemia View
None Refractory B-cell Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult patients View
None B-cell ALL View
None chemo-refractory View
None relapsed after allogeneic SCT View
None ineligible for allogeneic SCT View